AGP Executive Report
Last update: 9 hours agoHIV Prevention Access: Gilead and PAHO announced a milestone partnership to accelerate access to twice-yearly lenacapavir for HIV prevention (PrEP) across all PAHO Member States in Latin America and the Caribbean, using PAHO’s Regional Revolving Funds to support country-led rollout. Rare Disease Biologics: Sandoz and mAbxience signed a licensing, development, manufacturing and commercialization deal for an emicizumab biosimilar for haemophilia A, with mAbxience producing in GMP facilities in Argentina and Spain and Sandoz holding exclusive global commercialization rights excluding Argentina, Paraguay and Uruguay. Snakebite Preparedness: PAHO marked International Snakebite Awareness Day by highlighting the burden of snakebite across the Americas and reporting technical cooperation missions in Paraguay and other countries to strengthen surveillance, diagnosis, treatment protocols and timely access to antivenoms. Community Health Access: Paraguay’s bone marrow donor drive is set for Saturday, 19 September, with registration at Shopping del Sol and Shopping Mariano, using a buccal swab to help expand the national registry for patients needing compatible donors. Public Health & Environment: A study warns that plastic pollution hotspots across Latin America—including Paraguay—are creating major health risks as waste systems buckle and more plastic leaks into the environment. Local Wellness Note: Paraguay’s spring Youth Day on 21 September spotlights the mburucuyá (passion flower), widely embraced in culture and tradition.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Pharmaceutical Executive Daily: FDA Approves Fayuvi]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/24990778-912932933-69ad66ff9a88b963b53a43ee2436f89da07d52ad-1280x720-100x56.jpeg)
